Decoding Neurodegeneration: Pioneering Lipid Metabolism-Focused Research Laboratory

Neurological Diseases Research Group

THE PHILOSOPHY OF OUR RESEARCH

Mission - Vision - Values

VISION:

We seek a world where neurodegenerative diseases can be cured or prevented.

We want that with our research we contribute to discover new effective treatments for these devastating diseases, and even prevent them.

MISSION:

To understand the complex causes of neurodegenerative diseases, and decipher what there is in each person’s particular life that makes them more susceptible to suffering from one disease or another.

VALUES:

  • Research integrity
  • Quality
  • Reliability
  • Teamwork
  • Trust
  • Equality and diversity
about the lab

Ongoing Research Lines

Our lab investigates neurodegenerative diseases like Alzheimer’s, ALS, and frontotemporal dementia, focusing on their multifaceted causes and systemic impacts, including effects on metabolism and lifestyle factors. We adopt a holistic, multifactorial strategy in our research, integrating multi-omics and personalized medicine to develop tailored patient solutions. 

We have three main ongoing research lines:

Progression
85%
Progression
70%
Progression
55%
why is it important?

Some facts and figures

0 s

Every 3 seconds, someone in the world develops dementia

Source: Alzheimer's Disease International (ADI) World Alzheimer's Report, 2018.

0 M

An estimated 50 million people worldwide are living with Alzheimer's and other dementias.

Source:World Health Organization (WHO), 2020..

$ 0 T

The global cost of dementia is estimated at approximately US$1 trillion

Source:World Health Organization (WHO), 2019..

+ 0 %

Neurodegeneration research has increased by 20% in the last five years

Source: Trend analysis of scientific publications, Web of Science, 2023...

A summary of the most relevant peer-reviewed publications.

Mutation in the FUS nuclear localisation signal domain causes neurodevelopmental and systemic metabolic alterations

Discovery of Mitophagy Inhibitors with Therapeutic Potential in Different Familial Amyotrophic Lateral Sclerosis Mutations

Generation and analysis of innovative genomically humanized knockin SOD1, TARDBP (TDP-43), and FUS mouse models

Colaborations & networks:

National and International collaborations and networks:

 These collaborations involve sharing resources, knowledge, and expertise to advance understanding and treatment of different medical conditions. Additionally, collaboration between institutions and countries is promoted to enhance the impact of research and foster the exchange of ideas and findings.

  • ALGESCO Amyotrophic Lateral Sclerosis Genetic Spanish Consortium
  • Red  Glial- Red nacional. 
  • Exoned- Red nacional. 

 

EpilipidNet– CA 18105- Pan European Network in Lipidomics and  Epilipidomics. COST-Actions.   From 2020- Ongoing.

EATRIS: the European infrastructure for translational medicine-  in the section of patient Biomarkers, with the ALS Unit of the Hospital Clínico San Carlos  (from 2020- Ongoing).

MouseAge – The Cost –Action.  (Finished in 2020).